Efficient generation of osteoclasts from human induced pluripotent stem cells and functional investigations of lethal CLCN7-related osteopetrosis
Authors:
- Uta RösslerURUta Rössler
- Anna Floriane HennigAHAnna Floriane Hennig
- Johannes KoppJKJohannes Kopp
- Kent SøeKent Søe
- Lukas CyganekLCLukas Cyganek
- Giovanni ZifarelliGZGiovanni Zifarelli
- Salaheddine AliSASalaheddine Ali
- Maja von der HagenMHMaja von der Hagen
- Elisabeth Tamara SträsslerESElisabeth Tamara Strässler
Open Access
- 1 December 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 36 (8) , 1621-1635
Abstract
Human induced pluripotent stem cells (hiPSCs) hold great potential for modelling human diseases and the development of innovative therapeutic approaches. Here, we report on a novel, simplified differentiation method for forming functional osteoclasts from hiPSCs. The three‐step protocol starts with embryoid body formation, followed by hematopoietic specification, and finally osteoclast differentiation. We observed continuous production of monocyte‐like cells over a period of up to nine weeks, generating sufficient material for several osteoclast differentiations. The analysis of stage‐specific gene and surface marker expression proved mesodermal priming, the presence of monocyte‐like cells, and of terminally differentiated multinucleated osteoclasts, able to form resorption pits and trenches on bone and dentine in vitro. In comparison to peripheral blood mononuclear cell (PBMC)‐derived osteoclasts hiPSC‐derived osteoclasts were larger and contained a higher number of nuclei. Detailed functional studies on the resorption behaviour of hiPSC‐osteoclasts indicated a trend towards forming more trenches than pits and an increase in pseudo‐resorption. We used hiPSCs from an ARO patient (BIHi002‐A, ARO hiPSCs) with compound heterozygous missense mutations p.(G292E) and p.(R403Q) in CLCN7, coding for the Cl‐/H+‐exchanger ClC‐7, for functional investigations. The patient's leading clinical feature was a brain malformation due to defective neuronal migration. Mutant ClC‐7 displayed residual expression and retained lysosomal co‐localization with OSTM1, but only ClC‐7 harboring the mutation p.(R403Q) gave strongly reduced ion currents. An increased autophagic flux in spite of unchanged lysosomal pH was evident in undifferentiated ARO hiPSCs. ARO hiPSC‐derived osteoclasts showed an increased size compared to hiPSCs of healthy donors. They were not able to resorb bone, indicating a loss‐of‐function effect of the mutations. In summary, we developed a highly reproducible, straightforward hiPSC‐osteoclast differentiation protocol. We demonstrated that osteoclasts differentiated from ARO‐hiPSCs can be used as a disease model for ARO and potentially also other osteoclast‐related diseases.Keywords
Funding Information
- Berlin Institute of Health
- BCRT crossfield project GenoPro
- BIH Center for Regenerative Therapies (13GW0098, 13GW0099)
- European Community's Seventh Framework Programme (602300 (SYBIL))
- Deutsche Forschungsgemeinschaft (SFB1002 S01)
- Deutsche Forschungsgemeinschaft (SFB1002 S01)
This publication has 45 references indexed in Scilit:
- Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal AcidificationThe American Journal of Human Genetics, 2019
- Large-Scale Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Provides Granulocytes or Macrophages for Cell Replacement TherapiesStem Cell Reports, 2015
- Severe neuronopathic autosomal recessive osteopetrosis due to homozygous deletions affecting OSTM1Bone, 2013
- Osteopetrosis: genetics, treatment and new insights into osteoclast functionNature Reviews Endocrinology, 2013
- Lysosomal Pathology and Osteopetrosis upon Loss of H + -Driven Lysosomal Cl – AccumulationScience, 2010
- Lysosomal degradation of endocytosed proteins depends on the chloride transport protein ClC‐7The FASEB Journal, 2009
- Ion channels and transporters in osteoclastsArchives of Biochemistry and Biophysics, 2008
- Loss of the chloride channel ClC‐7 leads to lysosomal storage disease and neurodegenerationThe EMBO Journal, 2005
- Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and humanNature Medicine, 2003
- Loss of the ClC-7 Chloride Channel Leads to Osteopetrosis in Mice and ManCell, 2001